Thanks to research-driven advances in diagnosis, detection, and treatment, overall age-adjusted cancer death rates in the U.S. have decreased by 33 percent from 1991 to 2020, a reduction that translates into 3.8 million lives saved.
Learn MoreCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreLong-standing inequities in numerous social drivers of health contribute to significant disparities in the burden of preventable cancer risk factors.
Read the ReportNearly 153,000 people in the U.S. are expected to be diagnosed with colorectal cancer this year. Read about the prevention, screening, and treatment options for this type of cancer.
Learn MoreInvesting in Innovation: The AACR grants program sparks innovation in basic, translational, and clinical research by providing critical support to promising investigators at all career levels.
Read MoreMaking Treatment Decisions: Abigail Johnston shares how she has approached decisions about her cancer care since she was diagnosed with metastatic breast cancer in 2017.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through July 10. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More